Equities Analysts Offer Predictions for Itron Q2 Earnings

Itron, Inc. (NASDAQ:ITRI) – Equities researchers at Zacks Research cut their Q2 2027 earnings per share (EPS) estimates for Itron in a research note issued to investors on Tuesday, August 18th. Zacks Research analyst Team now forecasts that the scientific and technical instruments company will earn $1.67 per share for the quarter, down from their previous forecast of $2.21. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $6.40 per share. Zacks Research also issued estimates for Itron’s Q4 2027 earnings at $1.23 EPS and FY2028 earnings at $8.02 EPS.

Itron (NASDAQ:ITRI) last posted its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.29 by $0.30. Itron had a return on equity of 19.26% and a net margin of 11.90%.The firm had revenue of $562.90 million during the quarter, compared to analyst estimates of $566.34 million. During the same period last year, the company posted $1.62 EPS. The business’s quarterly revenue was down 7.2% on a year-over-year basis. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS.

ITRI has been the topic of a number of other research reports. Seaport Research Partners restated a “buy” rating and issued a $150.00 target price on shares of Itron in a report on Wednesday, July 29th. Stephens reiterated an “overweight” rating and set a $130.00 price target on shares of Itron in a research note on Wednesday, May 20th. Weiss Ratings reissued a “hold (c)” rating on shares of Itron in a research note on Wednesday, August 5th. Needham & Company LLC raised their target price on Itron from $116.00 to $128.00 and gave the company a “buy” rating in a report on Wednesday, July 29th. Finally, TD Cowen cut their target price on Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $131.33.

Itron Price Performance

ITRI stock opened at $98.86 on Thursday. The company has a debt-to-equity ratio of 0.96, a current ratio of 2.75 and a quick ratio of 2.29. The company’s 50-day moving average is $89.77 and its 200-day moving average is $90.11. The stock has a market capitalization of $4.33 billion, a PE ratio of 16.50, a price-to-earnings-growth ratio of 0.79 and a beta of 1.30. Itron has a 1 year low of $77.77 and a 1 year high of $142.00.

Insider Activity

In related news, SVP Donald L. Reeves III sold 319 shares of the business’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $26,914.03. Following the sale, the senior vice president directly owned 29,100 shares in the company, valued at approximately $2,455,167. The trade was a 1.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Joan S. Hooper sold 442 shares of the stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $37,291.54. Following the completion of the sale, the chief financial officer directly owned 117,478 shares in the company, valued at approximately $9,911,618.86. The trade was a 0.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 2,035 shares of company stock valued at $171,731 over the last quarter. Company insiders own 1.77% of the company’s stock.

Institutional Trading of Itron

A number of hedge funds have recently bought and sold shares of the company. Private Trust Co. NA grew its position in Itron by 112.4% during the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after acquiring an additional 145 shares during the last quarter. Employees Retirement System of Texas bought a new stake in Itron in the third quarter valued at approximately $32,000. PenderFund Capital Management Ltd. bought a new stake in Itron in the second quarter valued at approximately $35,000. Quantbot Technologies LP purchased a new stake in shares of Itron during the second quarter valued at approximately $36,000. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in shares of Itron by 29.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after purchasing an additional 101 shares during the period. Institutional investors own 96.19% of the company’s stock.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Zacks raised several earnings estimates. The firm increased its FY2026 EPS forecast to $6.35 from $5.97, lifted Q4 2026 EPS to $1.72 from $1.65, and raised FY2027 EPS to $5.90 from $5.86. It also made smaller increases to Q3 2026, Q1 2027, Q3 2027 and Q1 2028 estimates, suggesting modest confidence in Itron’s near-term operating performance. MarketBeat Itron analyst estimates
• Positive Sentiment: Itron was added to multiple Zacks Strong Buy lists. On August 19, the company appeared on Zacks’ #1-ranked momentum, value and general Strong Buy lists. These designations may attract additional investor interest, particularly because ITRI trades below its 52-week high and near its 50-day and 200-day moving averages. Zacks momentum stocks article
• Neutral Sentiment: Zacks continues to rate Itron Hold. Despite the estimate increases and Strong Buy list appearances, the firm has not formally upgraded its rating. The current-year consensus EPS estimate is approximately $6.40, broadly consistent with the revised FY2026 forecast. Itron’s latest reported quarter also showed an EPS beat, but revenue declined 7.2% year over year.
• Negative Sentiment: Some longer-term estimates were reduced. Zacks cut its Q2 2027 EPS forecast to $1.67 from $2.21 and lowered FY2028 EPS to $8.02 from $8.86. It also reduced Q2 2028 EPS to $1.87 from $1.97, tempering the bullish impact of the nearer-term upward revisions. GuruFocus Itron valuation article

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.